Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Vanguard Dividend Appreciation Index Fund ETF trades at $238.84. The key difference: Vanguard Dividend Appreciation Index Fund ETF is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VIG | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $239.03 |
52-Week Low | $23.09 | $204.09 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VIG trades at $238.84, up 0.09% with a bullish technical outlook from moving averages and a neutral oscillator stance. The ETF focuses on U.S. dividend growth stocks, offering a low 0.04% expense ratio and a recent dividend of $1.00 payable June 30, 2026. News highlights its role in defensive strategies amid market volatility, with comparisons to peers like SCHD and DGRO emphasizing its growth-oriented approach.
The outlook remains positive due to strong technical momentum and dividend stability, but risks include market sensitivity to interest rates and competition from higher-yield alternatives. Analyst sentiment is mixed, with some favoring VIG for long-term wealth building while others note underperformance versus rivals in yield-focused segments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
